Lurong Pan

2 months ago | einnews.com | Lurong Pan

Ainnocence Demonstrates Breakthrough AI Technology for Rapid Pandemic Response SAN FRANCISCO, CA, UNITED STATES, January 29, 2025 /EINPresswire.com/ -- Ainnocence has achieved significant milestones in applying artificial intelligence to accelerate antibody discovery for pandemic preparedness, demonstrating unprecedented speed and efficiency in developing broadly neutralizing antibodies against multiple viral strains.

Jan 6, 2025 | einnews.com | Lurong Pan

SAN FRANCISCO, CA, UNITED STATES, January 6, 2025 /EINPresswire.com/ -- Ainnocence Inc. introduces its breakthrough generative AI platform fundamentally transforming therapeutic protein engineering by eliminating traditional computational bottlenecks in drug discovery. In a significant departure from conventional approaches that rely heavily on time-consuming 3D structural computations, Ainnocence's platform introduces a paradigm shift in protein engineering.

Nov 25, 2024 | einnews.com | Lurong Pan

AI Breakthrough Ushers in New Era of Personalized Medicine • Creating therapeutic candidates in hours, not months • Optimizing multiple pharmacological factors for maximum effectiveness and safety • Successfully targeting complex biological structures, including previously "undruggable" targets Having a track record with over 60 completed biologics drug design projects for leading biotech companies and research institutions, Ainnocence has demonstrated expertise in: • Infectious Disease:...

Nov 11, 2024 | einnews.com | Lurong Pan

Turbocharging Drug Discovery: AI-Powered R&D is Transforming the Pharmaceutical Industry and Accelerating Breakthroughs SAN FRANCISCO, CA, UNITED STATES, November 11, 2024 /EINPresswire.com/ -- In a landmark shift that's revolutionizing pharmaceutical research and development, artificial intelligence is dramatically reshaping how we discover and develop new drugs.

Oct 28, 2024 | einnews.com | Lurong Pan

Revolutionizing Molecular Design beyond 3D modeling: Innovative R&D in Protein Language Models Unlocks New Frontiers SAN FRANCISCO, CA, UNITED STATES, October 28, 2024 /EINPresswire.com/ -- Ainnocence, a pioneering AI-driven biotech company, is pushing the boundaries of molecular design with its next-generation protein engineering platform, setting a new standard for innovation in immunology, oncology, infectious disease, and industrial enzyme design.